Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan B Fleischer

Showing results (31-40 of 282) with videos related to

Pageof 29
Sort By:
Journal of Drugs in Dermatology : JDD|July 6, 2023
Women of Childbearing Age With Hidradenitis Suppurativa Frequently Prescribed Medications With Pregnancy RiskGabrielle Marie Rivin, Alan B Fleischer
Dermatology Online Journal|August 17, 2023
Workforce requirements for keratinous cysts: clinicians expend 1200 full-time effort years annuallyGabrielle M Rivin, Alan B Fleischer
The Journal of Investigative Dermatology|February 4, 2025
Can We Trust Claims-Based Data?Steven R Feldman, Alan B Fleischer
Journal of Drugs in Dermatology : JDD|October 31, 2007
A method to gain a sense of relative efficacy of acne medications that have not yet been studiedSteven R Feldman, Alan B Fleischer
Photodermatology, Photoimmunology & Photomedicine|July 21, 2009
Commentary on 'Indoor tanning injuries: an evaluation of FDA adverse event reporting data'Steven R Feldman, Alan B Fleischer
Archives of Dermatology|September 23, 2009
Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxideMeghan I Dubina, Alan B Fleischer
Dermato-Endocrinology|May 20, 2016
Solar radiation and the incidence and mortality of leading invasive cancers in the United StatesAlan B Fleischer, Sarah E Fleischer
Drugs of Today (Barcelona, Spain : 1998)|August 9, 2006
Tacrolimus: focusing on atopic dermatitisChristie L Carroll, Alan B Fleischer
The Journal of Dermatological Treatment|November 5, 2016
Factors affecting the rise of treatment of resistant bacteria in skin and soft tissue infections in the United States: 1993-2012<sup></sup>Margaret E Wetzel, Alan B Fleischer
Dermatology Online Journal|February 23, 2026
Dupilumab prescribers used fewer days of systemic and topical corticosteroids compared with conventional immunosuppressant prescribersBrad R Woodie, Alan B Fleischer
Pageof 29

Showing results (31-40 of 282) with videos related to

Sort By:
Pageof 29
Journal of Drugs in Dermatology : JDD|July 6, 2023
Women of Childbearing Age With Hidradenitis Suppurativa Frequently Prescribed Medications With Pregnancy RiskGabrielle Marie Rivin, Alan B Fleischer
Dermatology Online Journal|August 17, 2023
Workforce requirements for keratinous cysts: clinicians expend 1200 full-time effort years annuallyGabrielle M Rivin, Alan B Fleischer
The Journal of Investigative Dermatology|February 4, 2025
Can We Trust Claims-Based Data?Steven R Feldman, Alan B Fleischer
Journal of Drugs in Dermatology : JDD|October 31, 2007
A method to gain a sense of relative efficacy of acne medications that have not yet been studiedSteven R Feldman, Alan B Fleischer
Photodermatology, Photoimmunology & Photomedicine|July 21, 2009
Commentary on 'Indoor tanning injuries: an evaluation of FDA adverse event reporting data'Steven R Feldman, Alan B Fleischer
Archives of Dermatology|September 23, 2009
Interaction of topical sulfacetamide and topical dapsone with benzoyl peroxideMeghan I Dubina, Alan B Fleischer
Dermato-Endocrinology|May 20, 2016
Solar radiation and the incidence and mortality of leading invasive cancers in the United StatesAlan B Fleischer, Sarah E Fleischer
Drugs of Today (Barcelona, Spain : 1998)|August 9, 2006
Tacrolimus: focusing on atopic dermatitisChristie L Carroll, Alan B Fleischer
The Journal of Dermatological Treatment|November 5, 2016
Factors affecting the rise of treatment of resistant bacteria in skin and soft tissue infections in the United States: 1993-2012<sup></sup>Margaret E Wetzel, Alan B Fleischer
Dermatology Online Journal|February 23, 2026
Dupilumab prescribers used fewer days of systemic and topical corticosteroids compared with conventional immunosuppressant prescribersBrad R Woodie, Alan B Fleischer
Pageof 29